JAGX — Jaguar Health Balance Sheet
0.000.00%
- $7.33m
- $33.33m
- $11.69m
- 26
- 66
- 16
- 27
Annual balance sheet for Jaguar Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 8.09 | 17.1 | 5.47 | 6.47 | 8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.56 | 2.14 | 2.47 | 2.18 | 1.65 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 17.8 | 28.4 | 22.3 | 28 | 32.2 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.677 | 1.73 | 1.7 | 1.67 | 1.4 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 42.8 | 53.3 | 47.5 | 50.8 | 53.4 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 13.2 | 15.5 | 30.3 | 14 | 19.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 25.6 | 41.7 | 48.1 | 45.8 | 43.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.2 | 11.6 | -0.657 | 4.96 | 9.77 |
| Total Liabilities & Shareholders' Equity | 42.8 | 53.3 | 47.5 | 50.8 | 53.4 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |